Gp120: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
Michal Harel (talk | contribs)
No edit summary
No edit summary
Line 1: Line 1:
[[Image:3tgs.jpg|left|200px]]
<StructureSection load='' size='450' side='right' scene='Journal:JBSD:41/Cv/1' caption=''>
 
<!--
The line below this paragraph, containing "STRUCTURE_3tgs", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
 
{{STRUCTURE_3tgs|  PDB=3tgs  | SIZE=400| SCENE= |right|CAPTION=Glycoprotein Gp120 dimer complex piperidine derivative, [[3tgs]] }}
 
 
 
 
 
 
 
 
 
 
 
 
 
'''Glycoprotein Gp120''', named for its molecular weight, is found on the surface of HIV envelope.  Gp120 is associated with Gp41.  It is involved in the binding of HIV to CD4 receptors thus attaching the virus to the host cell.  For more details see<br />
'''Glycoprotein Gp120''', named for its molecular weight, is found on the surface of HIV envelope.  Gp120 is associated with Gp41.  It is involved in the binding of HIV to CD4 receptors thus attaching the virus to the host cell.  For more details see<br />
*[[Hiv env proteins]]<br />
*[[Hiv env proteins]]<br />
*[[VRC01 gp120 complex]].
*[[VRC01 gp120 complex]].


===  Molecular Mechanism of HIV-1 gp120 Mutations That Reduce CD4 Binding Affinity <ref>doi 10.1080/07391102.2012.746946</ref>===
Despite abundant efforts in HIV research the HI-virus remains one of the most serious infectious health threats for human worldwide. Infection involves the entry of the virus into CD4 carrying cells and is mediated by the recognition of the <scene name='Journal:JBSD:41/Cv/2'>cellular CD4 surface protein</scene> (<span style="color:yellow;background-color:black;font-weight:bold;">colored in yellow</span>) by <scene name='Journal:JBSD:41/Cv/3'>gp120 of the viral envelope</scene> (<span style="color:lime;background-color:black;font-weight:bold;">colored in green</span>). The CD4-binding site of gp120 contains <scene name='Journal:JBSD:41/Cv/4'>two crucial loops</scene>, termed the <font color='blue'><b>‘CD4-binding loop’ (in blue)</b></font> and the <span style="color:salmon;background-color:black;font-weight:bold;">‘outer domain exit (ODE) loop’ (colored in salmon)</span>, respectively. Importantly, <scene name='Journal:JBSD:41/Cv/6'>this functional site</scene> is a key target site for gp120-ligands to interfere with the gp120-CD4 interaction and thereby hampering infection. <span style="color:white;background-color:black;font-weight:bold;">Carbons of the important residues are colored in white</span>, <font color='blue'><b>nitrogens in blue</b></font>, and <font color='red'><b>oxygens in red</b></font>. Therapeutic ligands include for instance soluble CD4 and its variants.
For the development of more potent gp120-ligands targeting the CD4-binding site we investigated two gp120-proteins from two clinical HIV isolates that exhibit a decreased affinity for soluble CD4. Each variant exhibits a set of simultaneous mutations in the CD4-binding loop and the ODE-loop. The <scene name='Journal:JBSD:41/Cv/7'>mutant gp120(3-2)</scene> exhibits three mutations in the CD4-binding loop (P369A, I371L, T373M) and two mutations in the ODE-loop (G471E, D474N). The <scene name='Journal:JBSD:41/Cv/8'>gp120(2-1)</scene> protein contains three simultaneous mutations: V372E, T373M in the CD4-binding loop, and D474N in the ODE-loop. <font color='magenta'><b>Carbons of the mutated residues are colored in white</b></font>, <font color='blue'><b>nitrogens in blue</b></font>, <font color='red'><b>oxygens in red</b></font>, and <span style="color:yellow;background-color:black;font-weight:bold;">sulfur in yellow</span>.  To understand the phenomenon of reduced CD4-binding on a structural level the two gp120 variants were modeled, each with its specific set of mutations, and simulated using molecular dynamics. The results show that the mutant glutamates of both variants play a key role for reduced CD4 binding by affecting the conformation of the CD4-binding and ODE-loop. This knowledge should be helpful to predict the resistance of novel gp120 mutants or to design gp120-ligands with improved binding properties.
</StructureSection>
__NOTOC__
==3D structures of Gp120==
==3D structures of Gp120==


Line 58: Line 43:


[[2bf1]], [[3fus]] - Gp120 core
[[2bf1]], [[3fus]] - Gp120 core
== References ==
<references/>

Revision as of 13:10, 20 November 2013

Glycoprotein Gp120, named for its molecular weight, is found on the surface of HIV envelope. Gp120 is associated with Gp41. It is involved in the binding of HIV to CD4 receptors thus attaching the virus to the host cell. For more details see

Molecular Mechanism of HIV-1 gp120 Mutations That Reduce CD4 Binding Affinity [1]

Despite abundant efforts in HIV research the HI-virus remains one of the most serious infectious health threats for human worldwide. Infection involves the entry of the virus into CD4 carrying cells and is mediated by the recognition of the (colored in yellow) by (colored in green). The CD4-binding site of gp120 contains , termed the ‘CD4-binding loop’ (in blue) and the ‘outer domain exit (ODE) loop’ (colored in salmon), respectively. Importantly, is a key target site for gp120-ligands to interfere with the gp120-CD4 interaction and thereby hampering infection. Carbons of the important residues are colored in white, nitrogens in blue, and oxygens in red. Therapeutic ligands include for instance soluble CD4 and its variants.

For the development of more potent gp120-ligands targeting the CD4-binding site we investigated two gp120-proteins from two clinical HIV isolates that exhibit a decreased affinity for soluble CD4. Each variant exhibits a set of simultaneous mutations in the CD4-binding loop and the ODE-loop. The exhibits three mutations in the CD4-binding loop (P369A, I371L, T373M) and two mutations in the ODE-loop (G471E, D474N). The protein contains three simultaneous mutations: V372E, T373M in the CD4-binding loop, and D474N in the ODE-loop. Carbons of the mutated residues are colored in white, nitrogens in blue, oxygens in red, and sulfur in yellow. To understand the phenomenon of reduced CD4-binding on a structural level the two gp120 variants were modeled, each with its specific set of mutations, and simulated using molecular dynamics. The results show that the mutant glutamates of both variants play a key role for reduced CD4 binding by affecting the conformation of the CD4-binding and ODE-loop. This knowledge should be helpful to predict the resistance of novel gp120 mutants or to design gp120-ligands with improved binding properties.


Drag the structure with the mouse to rotate


3D structures of Gp1203D structures of Gp120

Updated on 20-November-2013

Gp120 from HIVGp120 from HIV

3dnl, 3dnn, 3dno, 3tgq, 3tgr, 3tgt, 3tih - Gp120 core
1meq – GP120 C5 domain – NMR
1niz, 1nj0 - GP120 V3 loop – NMR

Gp120 binary complexGp120 binary complex

2ny7 - Gp120 core (mutant) + antibody B12
3idx, 3idy - Gp120 core (mutant) + antibody B13
3hi1 - Gp120 core + antibody F105
3se8, 3se9 - Gp120 + antibody VRC03
3ngb - Gp120 + antibody VRC01
3rjq - Gp120 core + antibody A12
3u2s - Gp120 V1V2 region + antibody PG9
3tgs, 4dko, 4dkp, 4dkq, 4dkr - Gp120 core + piperidine derivative

Gp120 ternary complexGp120 ternary complex

1gc1, 1g9m, 1g9n, 1rzj, 1rzk, 1yyl, 1yym – Gp120 core (mutant) + hCD4 N terminal (mutant) + antibody 17B
2b4c - Gp120 core (mutant) + hCD4 N terminal + antibody X5
2nxy, 2nxz, 2ny0, 2ny1, 2ny2, 2ny3, 2ny4, 2ny5, 2ny6 - Gp120 core (mutant) + hCD4 N terminal + antibody 17B
3jwd, 3jwo - Gp120 core + hCD4 N terminal + antibody 48D
2i5y, 2i60 - Gp120 core + hCD4 N terminal + antibody 17B

Gp120 from SIVGp120 from SIV

2bf1, 3fus - Gp120 core


ReferencesReferences

  1. Kassler K, Sticht H. Molecular mechanism of HIV-1 gp120 mutations that reduce CD4 binding affinity. J Biomol Struct Dyn. 2013 Jan 9. PMID:23297802 doi:10.1080/07391102.2012.746946

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Joel L. Sussman